Complete Platform Combines Masimo (NASDAQ:)’s Trade-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Increase the Put on OS by Google™ Ecosystem
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI), a number one international medical innovator, and Qualcomm (NASDAQ:) Applied sciences, Inc., whose Snapdragon ® branded platforms energy extraordinary shopper experiences, at the moment introduced that Masimo is partnering with Qualcomm Applied sciences to develop a next-generation smartwatch reference platform for authentic tools producers (OEMs) constructing Put on OS by Google (NASDAQ:) smartwatches. The powerhouse mixture of Masimo’s clinically confirmed, breakthrough biosensing applied sciences “ based mostly on its a long time of experience designing industry-leading hospital monitoring options “ and best-in-class Snapdragon wearable platforms will assist scale the wearable ecosystem. Forging the way forward for wearable gadgets, the reference platform will permit OEMs to extra effectively construct and produce high-performing, premium smartwatches to market. The platform can even profit from a strong suite of Masimo well being and wellness monitoring instruments that customers can belief to supply correct, dependable knowledge; it should use solely high-performance and ultra-low energy system-on-a-chips (SoCs) alongside industry-leading wi-fi and mobile communications from Qualcomm Applied sciences to allow a superior connectivity expertise.
This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/information/house/20240914175461/en/
Qualcomm Applied sciences and Masimo (Photograph: Business Wire)
Joe Kiani, Founder and CEO of Masimo, stated, We’re thrilled to have the ability to companion with Qualcomm Applied sciences, to whom we naturally turned to provide the chips in our personal forthcoming Masimo Freedom™ wearable, to craft a very outstanding reference platform. It is a platform pushed by the assumption that when key smartwatch parts are provided by the main consultants of their area, the harmonious entire produces one thing even higher than the sum of these glorious elements. In brief, Qualcomm Applied sciences and Masimo engineers are working collectively to optimize the ˜guts’ of the smartwatch. Masimo’s capacity to craft precision monitoring applied sciences and superior sign processing algorithms, mixed with meticulously engineered, high-performing, low-power Snapdragon methods, is a compelling basis. We anticipate this new wearable platform to supercharge smartwatch OEMs’ talents to create aggressive, fascinating smartwatches for customers in every single place. I sit up for partnering with an organization as well-known for its dedication to innovation as Masimo.
Dino Bekis, Vice President and Common Supervisor, Wearables and Blended Sign Options at Qualcomm Applied sciences, Inc., stated, Starting with Snapdragon W5+ Gen 1, this collaboration will considerably broaden the vary of smartwatch decisions for customers and additional improve the already distinctive Put on OS expertise. With these reference designs, OEMs will profit from sturdy, production-ready designs, incorporating Masimo’s state-of-the-art biosensing expertise and Qualcomm Applied sciences’ main Snapdragon wearable platforms. It’s going to in the end allow them to seamlessly convey their smartwatches to market quickly and at scale.
OEMs who undertake the brand new reference platform will proceed to design and produce their new smartwatches’ bodily exteriors and have inventive management over the looks of the consumer interface. The gadgets’ interiors, together with Snapdragon wearable platforms and Masimo biosensors, will likely be designed, offered, and examined by Masimo to make sure premium efficiency and an unmatched consumer expertise. Well being and wellness capabilities will function the identical biosensing improvements and analytics that energy Masimo W1 ® and forthcoming Masimo Freedom “ expertise based mostly on Masimo’s clinically confirmed, industry-leading Sign Extraction Expertise ® (SET ®). The Masimo reference platform will make all of those parts, options, and advantages out there for Put on OS smartwatch producers in an easy-to-implement, standardized bundle.
Snapdragon is a trademark or registered trademark of Qualcomm Integrated. Snapdragon is a product of Qualcomm Applied sciences, Inc. and/or its subsidiaries.
Put on OS by Google is a trademark of Google LLC.
@Masimo | #Masimo
About Masimo
Masimo (NASDAQ: MASI) is a world medical expertise firm that develops and produces a wide selection of industry-leading monitoring applied sciences, together with modern measurements, sensors, affected person displays, and automation and connectivity options. As well as, Masimo Client Audio is house to eight legendary audio manufacturers, together with Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to enhance life, enhance affected person outcomes, and cut back the price of care. Masimo SET ® Measure-through Movement and Low Perfusion™ pulse oximetry, launched in 1995, has been proven in over 100 unbiased and goal research to outperform different pulse oximetry applied sciences.1 Masimo SET ® has additionally been proven to assist clinicians cut back extreme retinopathy of prematurity in neonates,2 enhance CCHD screening in newborns,3 and, when used for steady monitoring with Masimo Affected person SafetyNet™ in post-surgical wards, cut back fast response staff activations, ICU transfers, and prices.4-5 Masimo SET ® is estimated for use on greater than 200 million sufferers in main hospitals and different healthcare settings all over the world,6 and is the first pulse oximetry in any respect 10 prime U.S. hospitals as ranked within the 2024 Newsweek World’s Greatest Hospitals itemizing.7 In 2005, Masimo launched rainbow ® Pulse CO-Oximetry expertise, permitting noninvasive and steady monitoring of blood constituents that beforehand may solely be measured invasively, together with whole hemoglobin (SpHb ®), oxygen content material (SpOC™), carboxyhemoglobin (SpCO ®), methemoglobin (SpMet ®), Pleth Variability Index (PVi ®), RPVi™ (rainbow ® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo launched the Root ® Affected person Monitoring and Connectivity Platform, constructed from the bottom as much as be as versatile and expandable as potential to facilitate the addition of different Masimo and third-party monitoring applied sciences; key Masimo additions embody Subsequent Technology SedLine ® Mind Perform Monitoring, O3 ® Regional Oximetry, and ISA™ Capnography with NomoLine ® sampling traces. Masimo’s household of steady and spot-check monitoring Pulse CO-Oximeters ® consists of gadgets designed to be used in quite a lot of medical and non-clinical eventualities, together with tetherless, wearable expertise, comparable to Radius-7 ®, Radius PPG ®, and Radius VSM™, transportable gadgets like Rad-67 ®, fingertip pulse oximeters like MightySat ® Rx, and gadgets out there to be used each within the hospital and at house, comparable to Rad-97 ® and the Masimo W1 ® Medical Watch. Masimo hospital and residential automation and connectivity options are centered across the Masimo Hospital Automation™ platform, and embody Iris ® Gateway, iSirona™, Affected person SafetyNet, Duplicate ®, Halo ION ®, UniView ®, UniView :60™, and Masimo SafetyNet ®. Its rising portfolio of well being and wellness options consists of Radius T º ® and Masimo W1 Sport. Further details about Masimo and its merchandise could also be discovered at www.masimo.com. Printed medical research on Masimo merchandise could be discovered at www.masimo.com/proof/featured-studies/function/.
References
- Printed medical research on pulse oximetry and the advantages of Masimo SET ® could be discovered on our web site. Comparative research embody unbiased and goal research that are comprised of abstracts offered at scientific conferences and peer-reviewed journal articles.
- Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants by way of Adjustments in Medical Follow and SpO2 Expertise. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Affect of pulse oximetry screening on the detection of duct dependent congenital coronary heart illness: a Swedish potential screening research in 39,821 newborns. BMJ. 2009;Jan 8;338.
- McGrath S et al. Surveillance Monitoring Administration for Common Care Items: Technique, Design, and Implementation. The Joint Fee Journal on High quality and Affected person Security. 2016 Jul;42(7):293-302.
- McGrath S et al. Inpatient Respiratory Arrest Related With Sedative and Analgesic Drugs: Affect of Steady Monitoring on Affected person Mortality and Extreme Morbidity. J Affected person Saf. 2020 14 Mar.
- Estimate: Masimo knowledge on file.
- https://www.newsweek.com/rankings/worlds-best-hospitals-2024/united-states
Ahead-Wanting Statements
This press launch consists of forward-looking statements as outlined in Part 27A of the Securities Act of 1933 and Part 21E of the Securities Trade Act of 1934, in reference to the Non-public Securities Litigation Reform Act of 1995. These forward-looking statements embody, amongst others, statements concerning the long run growth, effectivity, potential efficiency and adoption of the brand new Masimo reference platform (the Platform) and Masimo’s collaboration with Qualcomm. These forward-looking statements are based mostly on present expectations about future occasions affecting us and are topic to dangers and uncertainties, all of that are troublesome to foretell and plenty of of that are past our management and will trigger our precise outcomes to vary materially and adversely from these expressed in our forward-looking statements because of varied danger elements, together with, however not restricted to: dangers associated to our perception that Masimo’s distinctive noninvasive measurement applied sciences, together with the Platform, contribute to correct, dependable knowledge; dangers associated to our perception that Masimo noninvasive medical breakthroughs present cost-effective options and distinctive benefits; dangers associated to the idea that the Platform will likely be out there for integration into future OEM smartwatches; dangers associated to our perception that the Platform and OEMs will profit from the collaboration with Qualcomm; dangers associated to COVID-19; in addition to different elements mentioned within the “Risk Factors” part of our most up-to-date reviews filed with the Securities and Trade Fee (“SEC”), which can be obtained without cost on the SEC’s web site at www.sec.gov. Though we consider that the expectations mirrored in our forward-looking statements are affordable, we have no idea whether or not our expectations will show right. All forward-looking statements included on this press launch are expressly certified of their entirety by the foregoing cautionary statements. You might be cautioned to not place undue reliance on these forward-looking statements, which converse solely as of at the moment’s date. We don’t undertake any obligation to replace, amend or make clear these statements or the “Risk Factors” contained in our most up-to-date reviews filed with the SEC, whether or not because of new info, future occasions or in any other case, besides as could also be required underneath the relevant securities legal guidelines.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20240914175461/en/
Masimo
Evan Lamb
949-396-3376
elamb@masimo.com
Supply: Masimo
